Kamal K.E. Gadalla

Radically truncated MeCP2 rescues Rett syndrome-like neurological defects

Rebekah Tillotson, Jim Selfridge, Martha V. Koerner et al. · Nature · 2017 · 162 citations · Full text

Life Sciences, Molecular Genetics, Neuroscience +7

Improved Survival and Reduced Phenotypic Severity Following AAV9/MECP2 Gene Transfer to Neonatal and Juvenile Male Mecp2 Knockout Mice

Kamal K.E. Gadalla, Mark E.S. Bailey, R.C. Spike et al. · Molecular Therapy · 2012 · 156 citations · Full text

Life Sciences, Genetics, Neuroscience +17

Development of a Novel AAV Gene Therapy Cassette with Improved Safety Features and Efficacy in a Mouse Model of Rett Syndrome

Kamal K.E. Gadalla, Thishnapha Vudhironarit, Ralph D. Hector et al. · Molecular Therapy — Methods & Clinical Development · 2017 · 99 citations · Full text

Pharmacy, Genetics, Neuroscience +17

Inhibition of Piezo1 attenuates demyelination in the central nervous system

María Velasco‐Estevez, Kamal K.E. Gadalla, Núria Liñan‐Barba et al. · Glia · 2019 · 92 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Improved MECP2 Gene Therapy Extends the Survival of MeCP2-Null Mice without Apparent Toxicity after Intracisternal Delivery

Sarah E. Sinnett, Ralph D. Hector, Kamal K.E. Gadalla et al. · Molecular Therapy — Methods & Clinical Development · 2017 · 76 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +16